Trump Announces Plan to Slash US Drug Prices by 59%

US President Donald Trump has vowed to drastically reduce pharmaceutical prices in the United States by implementing a "Most Favoured Nation" policy, where the cost of prescription drugs sold in the US would be pegged to the lowest price paid by other countries for the same drug. Trump claims this move could result in a 59% reduction in prices, with some cases potentially seeing a drop of up to 80 or 90%. This plan, which relies on the goodwill of pharmaceutical companies to negotiate prices, is set to face legal challenges and opposition from the powerful drug and pharmaceutical lobby.

Key Takeaways:

• The "Most Favoured Nation" policy would tie the cost of prescription drugs sold in the US to the lowest price paid by other countries for the same drug.
• Trump aims to reduce US pharmaceutical prices by at least 59%, with some cases potentially seeing a drop of up to 80 or 90%.
• The plan relies on the goodwill of pharmaceutical companies to negotiate prices and may face legal challenges.
• The policy is in direct response to the EU's alleged "brutal" treatment of pharmaceutical companies, forcing them to lower their prices.
• Health Secretary Robert Kennedy Jr. praised the plan, stating Donald Trump as "the most willing president to stand up to the oligarchs."

Statistics:

• Trump claims the "Most Favoured Nation" policy could result in a 59% reduction in pharmaceutical prices for the US.
• Some cases may see a drop of up to 80 or 90% in prices.
• The plan may face resistance from the powerful drug and pharmaceutical lobby.
• Trump has previously attempted to lower US drug prices, with a similar proposal in 2017-2021 failing due to opposition from the pharmaceutical industry.

Sources:

• AFP